Individualised and Equitable Care of Type 2 Diabetes

Información del proyecto

EASY-Diabetes

Identificador del acuerdo de subvención: 877170

DOI

10.3030/877170

Proyecto cerrado

Fecha de la firma de la CE 23 Octubre 2019

Fecha de inicio 1 Noviembre 2019

Fecha de finalización 29 Febrero 2020

Financiado con arreglo a

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Coste total

€ 71 429,00

Aportación de la UE

€ 50 000,00

Coordinado por

ADJUVIA AB
Sweden

Periodic Reporting for period 1 - EASY-Diabetes (Individualised and Equitable Care of Type 2 Diabetes)

Período documentado: 2019-11-01 hasta 2020-02-29

Resumen del contexto y de los objetivos generales del proyecto

Diabetes is a common chronic disease that causes suffering for patients and vast costs for society. We have developed an e-health solution for diabetes that aims to improve patient outcomes, save time for healthcare professionals and reduce costs for society. Our SME Phase 1 feasibility study aimed to validate the commercial feasibility of our product with target market segments and key stakeholders. It included financial planning and specification of product features.

Trabajo realizado desde el comienzo del proyecto hasta el final del período abarcado por el informe y los principales resultados hasta la fecha

In the project, we have assessed the technical, commercial and financial feasibility of introducing our product to the market. This included identifying features needed for a fully commercialised solution, target markets and stakeholders. We have developed a strategy for introducing our product to the market, including regulatory requirements, operating costs and revenue projections.

Avances que van más allá del estado de la técnica e impacto potencial esperado (incluida la repercusión socioeconómica y las implicaciones sociales más amplias del proyecto hasta la fecha)

The outcomes of the project resulted in improvements to our plan for the next phase of the business. These improvements include changing some of our target markets, enhancing our implementation models and changing our cooperative strategy. We are thus in a better position to realise the long-term impact of our offering in terms of patient health, healthcare savings and job creation.

Logo for the product